Editas Medicine, Inc.
EDIT · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 31, 2026 | — | — | — | — | — |
| 2026 Q1 | May 5, 2026 | 2.83M | 6.37M | -0.26 | -0.30 | — |
| 2025 Q4 | March 9, 2026 | 24.74M | 8.35M | -0.06 | -0.27 | -4.51% |
| 2025 Q3 | November 10, 2025 | 7.54M | 8.45M | -0.28 | -0.38 | +5.56% |
| 2025 Q2 | August 12, 2025 | 3.58M | 1.82M | -0.63 | -0.41 | -3.90% |
| 2025 Q1 | May 12, 2025 | 4.66M | 706.10K | -0.43 | -0.51 | -2.60% |
| 2024 Q4 | March 5, 2025 | 30.60M | 640.25K | -0.55 | -0.39 | +16.48% |
| 2024 Q3 | November 4, 2024 | 61.00K | 28.90M | -0.75 | -0.76 | -1.03% |
| 2024 Q2 | August 7, 2024 | 513.00K | 5.08M | -0.82 | -0.69 | -12.18% |
| 2024 Q1 | May 8, 2024 | 1.14M | 7.90M | -0.76 | -0.63 | -11.36% |
| 2023 Q4 | February 28, 2024 | 60.05M | 7.94M | -0.23 | -0.52 | +24.94% |
| 2023 Q3 | November 3, 2023 | 5.34M | 3.42M | -0.55 | -0.64 | +18.21% |
| 2023 Q2 | August 2, 2023 | 2.89M | 4.17M | -0.56 | -0.76 | +5.66% |
| 2023 Q1 | May 5, 2023 | 9.85M | 3.01M | -0.71 | -0.79 | +12.04% |
| 2022 Q4 | February 22, 2023 | 6.54M | 3.66M | -0.88 | -0.84 | +6.21% |
| 2022 Q3 | November 2, 2022 | 42.00K | 4.39M | -0.81 | -0.87 | +1.10% |